Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A secret that underlies Parkinson's disease: The damaging cycle
Feiyi Sun, Yulin Deng, Xiaowei Han, et al.
Neurochemistry International (2019) Vol. 129, pp. 104484-104484
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities
Jannik Prasuhn, Ryan L. Davis, Kishore R. Kumar
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 109
Mitochondrial Dysfunction in Parkinson’s Disease: From Mechanistic Insights to Therapy
Xiaoyan Gao, Tuo Yang, Ying Gu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 74
α-Synuclein in Parkinson's disease and advances in detection
Rong Chen, Xuan Gu, Xiaoying Wang
Clinica Chimica Acta (2022) Vol. 529, pp. 76-86
Closed Access | Times Cited: 32
Involvement of miRNA on epigenetics landscape of Parkinson's disease: From pathogenesis to therapeutics
Sai Nikhil Uppala, Kamatham Pushpa Tryphena, Padmashri Naren, et al.
Mechanisms of Ageing and Development (2023) Vol. 213, pp. 111826-111826
Closed Access | Times Cited: 19
The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson’s disease
Junhan Liang, Zhirong Wan, Cheng Qian, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 7
The effects of NLRP3 inflammasome inhibition or knockout in experimental apical periodontitis induced in mice
Carolina Maschietto Pucinelli, Raquel Assed Bezerra da Silva, Paulo Nelson‐Filho, et al.
Clinical Oral Investigations (2024) Vol. 28, Iss. 5
Closed Access | Times Cited: 6
Role of Mesenchymal Stem Cells in Counteracting Oxidative Stress—Related Neurodegeneration
Cristina Angeloni, Martina Gatti, Cecilia Prata, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3299-3299
Open Access | Times Cited: 40
Regulation of mitochondrial dysfunction induced cell apoptosis is a potential therapeutic strategy for herbal medicine to treat neurodegenerative diseases
Ruolan Li, Ling‐Yu Wang, Huxinyue Duan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Mitochondria-Associated MicroRNAs and Parkinson’s Disease
Gayatri Reddy Aaluri, Yashmit Choudhary, Subodh Kumar
Neuroscience Insights (2024) Vol. 19
Open Access | Times Cited: 5
Neurotoxicity and Underlying Mechanisms of Endogenous Neurotoxins
Yanlu Cao, Bo Li, Nafissa Ismail, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12805-12805
Open Access | Times Cited: 31
The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson’s disease
Zixuan Chen, Madiha Rasheed, Yulin Deng
Brain Pathology (2021) Vol. 32, Iss. 3
Open Access | Times Cited: 29
The Protective Effects of Mogroside V Against Neuronal Damages by Attenuating Mitochondrial Dysfunction via Upregulating Sirtuin3
Hanjiang Luo, Caixia Peng, Xiaofeng Xu, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 4, pp. 2068-2084
Closed Access | Times Cited: 22
Methylglyoxal Formation—Metabolic Routes and Consequences
Janka Vašková, Gabriela Kováčová, Jakub Pudelský, et al.
Antioxidants (2025) Vol. 14, Iss. 2, pp. 212-212
Open Access
Galangin reduces MPTP-induced dopamine neuron injury via the autophagy dependent-PI3K/AKT pathway
Liping Huang, Qiaofeng Li, Jingyi Wu, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Emerging Potential of Exosomal Non-coding RNA in Parkinson’s Disease: A Review
Peng Zhang, Madiha Rasheed, Junhan Liang, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 17
Escalating Bi-Directional Feedback Loops between Proinflammatory Microglia and Mitochondria in Ageing and Post-Diagnosis of Parkinson’s Disease
Shane Michael Ravenhill, Andrew Evans, Sheila G. Crewther
Antioxidants (2023) Vol. 12, Iss. 5, pp. 1117-1117
Open Access | Times Cited: 8
The onjisaponin B metabolite tenuifolin ameliorates dopaminergic neurodegeneration in a mouse model of Parkinson’s disease
Fang Peng, Linyu Lu, Fei Wei, et al.
Neuroreport (2020) Vol. 31, Iss. 6, pp. 456-465
Closed Access | Times Cited: 23
Non-Coding RNAs in Parkinson's Disease: Regulating SNCA and Alpha-Synuclein Aggregation
Lakshmi Thangavelu, Ehssan Moglad, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 261, pp. 155511-155511
Closed Access | Times Cited: 2
Inhibition of alpha-synuclein aggregation by AM17, a synthetic resveratrol derivative
Edward Chau, Hyun‐Joo Kim, Jineun Shin, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 574, pp. 85-90
Open Access | Times Cited: 14
Dysfunctional energy and future perspective of low dose H2O2 as protective agent in neurodegenerative disease
Sri Widyarti, Syahputra Wibowo, Akhmad Sabarudin, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e18123-e18123
Open Access | Times Cited: 3
Quantitative proteomic profiling of the rat substantia nigra places glial fibrillary acidic protein at the hub of proteins dysregulated during aging: Implications for idiopathic Parkinson's disease
Yolanda Gómez‐Gálvez, Heidi R. Fuller, Silvia A. Synowsky, et al.
Journal of Neuroscience Research (2020) Vol. 98, Iss. 7, pp. 1417-1432
Open Access | Times Cited: 4
Molecular docking investigation of the amantadine binding to the enzymes upregulated or downregulated in Parkinson’s disease
Mihaela Ionescu
ADMET & DMPK (2020) Vol. 8, Iss. 2, pp. 149-149
Open Access | Times Cited: 4
The effect of water-soluble pristine C60 fullerene on 6-OHDA-induced Parkinson’s disease in rats
В. О. Стецька, Taisa Dovbynchuk, Y. S. Makedon, et al.
Regulatory Mechanisms in Biosystems (2021) Vol. 12, Iss. 4, pp. 599-607
Open Access | Times Cited: 4
Vulnerabilities of Aging and Biological Effects of Physical Activity Provide New Clues for Interventions in Parkinson’s Disease
Nicolaas I. Bohnen
The Journals of Gerontology Series A (2020) Vol. 75, Iss. 4, pp. 687-689
Open Access | Times Cited: 1
Vinpocetine Exerts Neuroprotective Effects via Downregulating α-Syn in Rotenone-induced Cellular Models of Parkinson’s Disease
Meng Ji, Jihua Xu, Heyin Mi, et al.
Letters in Drug Design & Discovery (2023) Vol. 21, Iss. 14, pp. 3060-3067
Closed Access
Page 1 - Next Page

Scroll to top